Cargando…
Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance
Candida glabrata is a major pathogenic yeast in humans that is known to rapidly acquire resistance to triazole and echinocandin antifungal drugs. A mutator genotype (MSH2 polymorphism) inducing a mismatch repair defect has been recently proposed to be responsible for resistance acquisition in C. gla...
Autores principales: | Dellière, Sarah, Healey, Kelley, Gits-Muselli, Maud, Carrara, Bastien, Barbaro, Alessandro, Guigue, Nicolas, Lecefel, Christophe, Touratier, Sophie, Desnos-Ollivier, Marie, Perlin, David S., Bretagne, Stéphane, Alanio, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179511/ https://www.ncbi.nlm.nih.gov/pubmed/28066361 http://dx.doi.org/10.3389/fmicb.2016.02038 |
Ejemplares similares
-
Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
por: Healey, Kelley R., et al.
Publicado: (2018) -
Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance
por: Grosset, Marine, et al.
Publicado: (2016) -
Comparison of MultiLocus Sequence Typing (MLST) and Microsatellite Length Polymorphism (MLP) for Pneumocystis jirovecii genotyping
por: Gits-Muselli, Maud, et al.
Publicado: (2020) -
No Impact of Fluconazole to Echinocandins Replacement as First-Line Therapy on the Epidemiology of Yeast Fungemia (Hospital-Driven Active Surveillance, 2004–2017, Paris, France)
por: Bretagne, Stéphane, et al.
Publicado: (2021) -
The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Candida glabrata Colonization Mouse Model
por: Healey, Kelley, et al.
Publicado: (2017)